Advisory Services Network’s CRISPR Therapeutics CRSP Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$758K Buy
13,470
+3,509
+35% +$197K 0.01% 952
2025
Q1
$339K Sell
9,961
-96
-1% -$3.27K 0.01% 1228
2024
Q4
$396K Sell
10,057
-7,629
-43% -$300K 0.01% 1150
2024
Q3
$955K Hold
17,686
0.02% 731
2024
Q2
$955K Buy
17,686
+112
+0.6% +$6.05K 0.02% 731
2024
Q1
$1.2M Sell
17,574
-100
-0.6% -$6.82K 0.03% 622
2023
Q4
$1.11M Buy
17,674
+3,854
+28% +$241K 0.03% 595
2023
Q3
$627K Sell
13,820
-706
-5% -$32K 0.02% 815
2023
Q2
$815K Buy
14,526
+170
+1% +$9.54K 0.02% 698
2023
Q1
$649K Buy
14,356
+11,907
+486% +$539K 0.02% 792
2022
Q4
$99.6K Sell
2,449
-635
-21% -$25.8K ﹤0.01% 1622
2022
Q3
$202K Sell
3,084
-3,203
-51% -$210K 0.01% 1202
2022
Q2
$382K Sell
6,287
-7,133
-53% -$433K 0.01% 950
2022
Q1
$842K Buy
13,420
+1,069
+9% +$67.1K 0.02% 680
2021
Q4
$936K Sell
12,351
-435
-3% -$33K 0.03% 645
2021
Q3
$1.43M Buy
12,786
+337
+3% +$37.7K 0.05% 478
2021
Q2
$2.02M Buy
12,449
+2,291
+23% +$371K 0.06% 391
2021
Q1
$1.24M Buy
10,158
+1,848
+22% +$225K 0.05% 477
2020
Q4
$1.27M Buy
8,310
+7,169
+628% +$1.1M 0.05% 422
2020
Q3
$95K Buy
+1,141
New +$95K ﹤0.01% 1277
2020
Q2
Sell
-674
Closed -$29K 1364
2020
Q1
$29K Hold
674
﹤0.01% 1645
2019
Q4
$41K Buy
674
+400
+146% +$24.3K ﹤0.01% 1597
2019
Q3
$13K Hold
274
﹤0.01% 2039
2019
Q2
$13K Buy
274
+200
+270% +$9.49K ﹤0.01% 2037
2019
Q1
$3K Hold
74
﹤0.01% 2226
2018
Q4
$2K Hold
74
﹤0.01% 2289
2018
Q3
$3K Hold
74
﹤0.01% 2207
2018
Q2
$4K Sell
74
-921
-93% -$49.8K ﹤0.01% 2089
2018
Q1
$45K Buy
+995
New +$45K ﹤0.01% 1360
2017
Q4
Sell
-100
Closed -$2K 2542
2017
Q3
$2K Hold
100
﹤0.01% 2132
2017
Q2
$2K Hold
100
﹤0.01% 2089
2017
Q1
$2K Buy
+100
New +$2K ﹤0.01% 1951